Personalized Active Immunotherapy: Clinical Trials

1 trial for Personalized Active Immunotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Personalized Active Immunotherapy: new trials by email Literature Review of Personalized Active Immunotherapy trials Research Report on Personalized Active Immunotherapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance Therapy
Active Immunotherapy, after 6 courses of routine consolidation chemotherapy, during 6 courses of routine consolidation chemotherapy - Acute Myeloid Leukemia, Personalized Active Immunotherapy
Phase 1RecruitingFujian Medical University Union Hospital902024-09-012026-05-01

Narrower conditions

Leukemia, Myeloid, Acute (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Immunotherapy, Active (1)

Sponsors

Fujian Medical University Union Hospital (1)

Countries

China (1)

Top investigators

Meijuan Huang (1)